/stocks — the workspaceLOADING
CYTOKINETICS INC (CYTK) is a pharmaceutical preparations company. Piotroski F-Score 2/8. 41 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-06 from CYTK's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on CYTK plus an auto-SWOT — built from CYTK's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate CYTK using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Gilbert CisnerosU.S. Representative · CA-39 | BUY | $1,001 - $15,000 | filed 2026-07-02 |
| Malik Fady IbrahamEVP Research & Development | SELL | $303K | view → |
| Lee SungEVP, Chief Financial Officer | SELL | $98K | view → |
| Callos AndrewEVP, Chief Commercial Officer | SELL | $1.3M | view → |
| Blum Robert IPresident & CEO | SELL | $637K | view → |
| Lee SungEVP, Chief Financial Officer | SELL | $266K | view → |
| Lee SungEVP, Chief Financial Officer | SELL | $3.2M | view → |
| Malik Fady IbrahamEVP Research & Development | SELL | $278K | view → |
| Blum Robert IPresident & CEO | SELL | $528K | view → |
Projected from CYTK's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment CYTK files its announcement.
CYTK has sold off after 4 of its last 7 earnings reports.
Large earnings reactions have been common.
CYTK has traded lower after most recent earnings releases.
A more typical earnings reaction has been approximately ±7.9%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-05 | +13.3% |
| 2026-02-24 | -7.9% |
| 2025-11-05 | +1.1% |
| 2025-08-07 | -2.9% |
| 2025-05-06 | -9.9% |
| 2025-02-27 | -1.8% |
| 2024-08-08 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +8.9% |